CPTAC

A recent investigation by the National Cancer Institute's Cancer Genome Atlas consortium into the genetic underpinnings of breast tumors also offers a glimpse of the benefits of including proteomic data in such analyses.

With proteomics researchers from around the globe gathered in Boston last week for the Human Proteome Organization's 11th annual meeting, scientists and officials from the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium offered an update on the

The National Cancer Institute's Small Business Innovation Research Development Center this week announced $10 million in new contract funding opportunities, including several for proteomics research reagents.

The question of proteomics' place in the larger world of life science research drove discussion this week at the Human Proteome Organization's 11th annual meeting in Boston as researchers gathered to report on the field's progression and potential as well as the obstac

VANCOUVER, BC – At the American Society for Mass Spectrometry annual meeting here this week a number of major vendors reiterated their commitment to moving their instruments into the clinic (

Myriad RBM is collaborating with researchers at the Max Planck Institute of Biochemistry and the Bavarian Red Cross Blood Donor BioBank to identify protein biomarkers for the early detection of colon cancer.

The National Cancer Institute's Clinical Proteomic Technologies for Cancer Initiative this week issued a request for targets for monoclonal antibody production and characterization as part of its Antibody Characterization Program.

By Adam Bonislawski

By Adam Bonislawski

By Adam Bonislawski